Brant Point Investment Management LLC decreased its holdings in shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) by 22.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,500 shares of the medical research company’s stock after selling 30,000 shares during the quarter. PRA Health Sciences comprises approximately 0.9% of Brant Point Investment Management LLC’s investment portfolio, making the stock its 21st biggest holding. Brant Point Investment Management LLC owned about 0.17% of PRA Health Sciences worth $7,764,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the company. First Bank & Trust grew its position in shares of PRA Health Sciences by 1.6% during the 2nd quarter. First Bank & Trust now owns 3,211 shares of the medical research company’s stock worth $241,000 after buying an additional 52 shares during the period. Renaissance Group LLC grew its position in shares of PRA Health Sciences by 2.5% during the 2nd quarter. Renaissance Group LLC now owns 5,239 shares of the medical research company’s stock worth $393,000 after buying an additional 126 shares during the period. State Board of Administration of Florida Retirement System grew its position in shares of PRA Health Sciences by 0.6% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 21,892 shares of the medical research company’s stock worth $1,428,000 after buying an additional 140 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of PRA Health Sciences by 12.0% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,488 shares of the medical research company’s stock worth $112,000 after buying an additional 160 shares during the period. Finally, Los Angeles Capital Management & Equity Research Inc. grew its position in shares of PRA Health Sciences by 1.9% during the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 8,505 shares of the medical research company’s stock worth $638,000 after buying an additional 160 shares during the period. Institutional investors own 98.37% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/20/brant-point-investment-management-llc-has-7-76-million-stake-in-pra-health-sciences-inc-prah.html.

Shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) traded up 1.32% on Wednesday, reaching $76.11. 310,753 shares of the company were exchanged. PRA Health Sciences, Inc. has a 12 month low of $50.87 and a 12 month high of $80.99. The company has a market cap of $4.77 billion, a price-to-earnings ratio of 49.13 and a beta of 0.45. The company’s 50-day moving average price is $75.71 and its 200 day moving average price is $70.59.

PRA Health Sciences (NASDAQ:PRAH) last released its earnings results on Monday, August 7th. The medical research company reported $0.62 earnings per share for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.10). The firm had revenue of $457.90 million for the quarter, compared to analyst estimates of $447.79 million. PRA Health Sciences had a net margin of 5.15% and a return on equity of 21.17%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.63 EPS. On average, equities research analysts expect that PRA Health Sciences, Inc. will post $3.19 EPS for the current year.

In other PRA Health Sciences news, VP Linda Baddour sold 100,000 shares of the stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $74.85, for a total transaction of $7,485,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Pra Investors L.P. Kkr sold 9,500,000 shares of the stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $74.85, for a total transaction of $711,075,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 10,000,000 shares of company stock valued at $748,500,000 in the last three months. Insiders own 2.10% of the company’s stock.

Several equities research analysts have recently commented on PRAH shares. Jefferies Group LLC set a $73.00 price target on shares of PRA Health Sciences and gave the stock a “buy” rating in a research report on Thursday, June 1st. Credit Suisse Group restated an “outperform” rating and set a $76.00 price objective (up previously from $69.00) on shares of PRA Health Sciences in a report on Tuesday, June 6th. Bank of America Corporation began coverage on shares of PRA Health Sciences in a report on Monday, June 26th. They set a “buy” rating and a $89.00 price objective for the company. Citigroup Inc. restated a “buy” rating and set a $90.00 price objective (up previously from $73.00) on shares of PRA Health Sciences in a report on Wednesday, June 28th. Finally, BidaskClub cut shares of PRA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. PRA Health Sciences presently has a consensus rating of “Buy” and a consensus target price of $84.50.

About PRA Health Sciences

PRA Health Sciences, Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.